Month: March 2022

– Embark Successfully Completed Public Listing in November – – Embark Secures 14,200 Truck Reservations Under Partner Development Program – – Embark to Enable First Autonomous Trucks for Knight-Swift in 2022 as Part of Industry-First Truck Transfer Program – SAN FRANCISCO, March 17, 2022 (GLOBE NEWSWIRE) — Embark Technology, Inc. (Nasdaq: EMBK, “Embark” or the “Company”), a leading developer of autonomous technology for the trucking industry, today announced financial results for its fourth quarter ended December 31, 2021. “The past year has been momentous for Embark as we continued executing on our mission to create a safer, more efficient, and more sustainable trucking industry,” said Alex Rodrigues, CEO of Embark. “As the industry’s longest-running autonomous truck program, we continued to achieve a number of industry-firsts...

THE COLONY, Texas, March 17, 2022 (GLOBE NEWSWIRE) — Quest Resource Holding Corporation (NASDAQ: QRHC) (“Quest” or the “Company”), a national leader in environmental waste and recycling services, today announced financial results for the fourth quarter and year ended December 31, 2021. Fourth Quarter 2021 HighlightsRevenue was $46.4 million, a 67.7% increase compared with the fourth quarter of 2020. Gross profit was $8.7 million, a 56.2% increase compared with the fourth quarter of 2020. Gross margin was 18.8% of revenue compared with 20.2% during the fourth quarter of 2020. GAAP net loss per share attributable to common stockholders was ($0.03) per basic and diluted share, compared with net income of $0.01 per basic and diluted share during the fourth quarter of 2020. Adjusted EBITDA was $3.3 million, an 83.8% increase...

Conference call and webcast today at 4:30 p.m. ET NEWARK, Calif., March 17, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced corporate updates and financial results for the fourth quarter and fiscal year ended December 31, 2021. Sujal Shah, President and CEO of CymaBay, stated, “2021 was a year of growth for CymaBay and included accomplishments that position CymaBay for long-term success. A non-dilutive, risk-sharing development financing agreement of up to $100 million signed with Abingworth in July, together with a $75 million public equity offering in November support the completion of our ongoing Phase 3 program for seladelpar in PBC. We now have over 120 sites...

Conference call and live webcast at 4:30 p.m. ET today NEWTOWN, Pa., March 17, 2022 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced financial results for the twelve months ended December 31, 2021, and provided a business update. Highlights for the fourth quarter of 2021 and recent weeks include:The Phase 1 solid tumor trials of narazaciclib in the United States and China are ongoing with no dose-limiting toxicities observed to date. The trial in the United States is currently enrolling into its fourth dose cohort, which is evaluating a 160 mg daily dose administered orally on each day of a 28-day treatment cycle. The trial in China is enrolling into its fifth dose...

AUSTIN, Texas, March 17, 2022 (GLOBE NEWSWIRE) — Ideal Power Inc. (“Ideal Power” or the “Company”) (Nasdaq: IPWR), pioneering the development and commercialization of the highly efficient and broadly patented B-TRAN™ bidirectional semiconductor power switch, reported results for its fourth quarter and full year ended December 31, 2021. “Fourth quarter 2021 capped off a year of strong progress along our roadmap to commercialize B-TRAN™ as an innovative technology addressing and enabling high-growth, immediate demand markets with the potential to displace conventional power semiconductor solutions in many applications. We advanced our B-TRAN™ test and evaluation program, adding leading commercial enterprises in each of our target market segments. We also made significant progress under the U.S. Navy/Naval Sea Systems Command (NAVSEA)...

Total Revenue and Income growth of 87% year-over-year in 4Q21 to R$1.9 billion;Record Quarterly Net Addition of 378k Clients, reaching 1.8 million Active Clients;MSMB Take Rate sequential increase to 1.71% in 4Q21 and 2.02% in January/22 GEORGE TOWN, Grand Cayman, March 17, 2022 (GLOBE NEWSWIRE) — StoneCo Ltd. (Nasdaq: STNE) (“Stone” or the “Company”), a leading provider of financial technology and software solutions that empowers merchants to conduct commerce seamlessly across multiple channels, today reports its financial results for its fourth quarter and fiscal year ended December 31, 2021. “Dear Shareholders, As we report our Q4 and full-year 2021 results, I want to reflect on the last year, lessons we learned, and actions we’ve taken to refocus and position our company for continued growth and improved profitability in 2022.  2021...

ATHENS, Greece, March 17, 2022 (GLOBE NEWSWIRE) —  Dynagas LNG Partners LP (NYSE: “DLNG”) (“Dynagas Partners” or the “Partnership”), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced its results for the three months and year ended December 31, 2021. Fourth Quarter Highlights:Net income and earnings per common unit (basic and diluted) of $16.9 million and $0.38, respectively; Adjusted Net Income(1)of $11.4 million and Adjusted Earnings(1) per common unit (basic and diluted) of $0.23; Adjusted EBITDA(1) $24.7 million; 100% fleet utilization(2); and Declared and paid cash distribution of $0.5625 per unit on its Series A Preferred Units (NYSE: “DLNG PR A”) for the period from August 12, 2021 to November 11, 2021 and $0.546875 per unit on the Series B Preferred Units (NYSE: “DLNG PR B”) for the period...

2021 fourth quarter revenue totaled $19.7 million an increase of 53% year-over-year and 17.2% sequentially Net revenue for 2021 increased 34% year-over-year to $59.8 million LITTLE ROCK, Ark., March 17, 2022 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, powered by artificial intelligence (AI) that serves brands and agencies, today announced its financial results for the fourth quarter and full year ending December 31, 2021. Rich Howe, Chief Executive Officer of Inuvo, commented, “We reported another strong fourth quarter, delivering $19.7 million in revenue, an increase of 53% year-over-year and 17% sequentially. Year-over-year revenue growth from the second quarter through the fourth quarter of 2021 was 66%, 83% and now 53%, a testament to the demand for both the ValidClick and...

FREMONT, Calif., March 17, 2022 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and year ended December 31, 2021, as well as business updates. “We are in discussions with the FDA to determine if there is a viable option to pursue approval of M207 using the currently available clinical data. In addition, we are actively evaluating financial and strategic alternatives in collaboration with external advisors, with a goal of maximizing value,” said Steven Lo, president and chief executive officer of Zosano. “We believe our proprietary transdermal microneedle patch technology offers potential therapeutic and practical benefits to patients.” Select Recent Business UpdatesRaised approximately $15.4 million in gross proceeds...

Full year SaaS revenue of $85.6 million, up 64% year-over-yearTotal ARR of $159.2 million, up 34% year-over-yearCloud user base exceeds 9 million JERSEY CITY, N.J., March 17, 2022 (GLOBE NEWSWIRE) — AvePoint (NASDAQ: AVPT), the most advanced SaaS and data management solutions provider, today announced financial results for the fourth quarter and full year ended December 31, 2021. “AvePoint’s fourth quarter performance was a solid finish to our first year as a public company, which was highlighted by 64% SaaS revenue growth and 34% ARR growth, with an additional 36% growth in customers with ARR above 100k,” said Dr. Tianyi Jiang (TJ), CEO and Co-Founder, AvePoint. “As enterprises continue their long-term shift to SaaS based platforms, and we see increased application usage in 2022 and beyond, we believe we are well positioned to...